Skip to main content
. 2020 May 26;13(6):1199–1207. doi: 10.1111/cts.12804

Table 1.

Estimated CLintliver using the canonical and new approaches

Drugs a K M (µM) b Vmax (pmol∙min−1∙pmol CYP−1) c , d Major CYP CYP abundance in HLM (pmol/mg) E~T (µmol) c,d E T (µM) e CLintliver (mL/min)
Canonical f New g
Coumarin 0.75 39.2 2A6 30.7 ~ 56.2 9 , 22 1.77 ~ 5.31 1.03 ~ 3.10 92,457 ~ 277,683 38,924 ~ 54,122
Paclitaxel 5.5 4.64 2C8 26.9 ~ 43.0 9 , 22 1.55 ~ 4.06 0.90 ~ 2.37 1,308 ~ 3,429 1,123 ~ 2,396
Propafenone 0.12 4.83 2D6 9.34 ~ 17.2 11 , 22 0.54 ~ 1.63 0.31 ~ 0.95 21,626 ~ 65,339 5,982 ~ 7,340
Midazolam 1.6 24.4 3A4 32.6 ~ 60.4 11 , 22 1.88 ~ 5.71 1.10 ~ 3.33 28,630 ~ 87,025 16,995 ~ 28,246
Indinavir 2.31 9.28 7,535 ~ 22,905 5,112 ~ 9,382
Cyclosporine 5 4.44 1,666 ~ 5,063 1,366 ~ 3,039
Saquinavir 0.61 40.4 124,247 ~ 377,671 44,443 ~ 58,479
Cabazitaxel 2.1 9.5 8,499 ~ 25,835 5,586 ~ 9,992
Docetaxel 1.1 0.20 348 ~ 1,059 175 ~ 263
Valspodar 1.3 2.49 3,588 ~ 10,906 1,947 ~ 3,062
Felodipine 2.81 36.2 24,156 ~ 73,427 17,381 ~ 33,606

CLintliver, intrinsic clearance of the liver; HLM, human liver microsome; K M, Michaelis‐Menten constant; V max, maximal rate of metabolism.

a

See Methods for the criteria for the drug selections.

b

See Supplementary Excel File for references of K M and V max values.

c

Obtained by dividing the measured rate per mg of the microsomes by the rate per pmol CYP with mean population abundance of CYP (pmol/mg): CYP2A6 (45.37), CYP2C8 (32.30), CYP2D6 (13.26), and CYP3A4 (45.07). 9 , 10 , 11 , 22

d

The hepatic CYP amount is estimated by multiplying CYP abundance in HLM (pmol/mg) by MPPGL and liver weight (see Methods for details).

e

The hepatic CYP concentration is estimated based on the assumption that CYPs are evenly distributed (see Methods for details).

f

Canonical CLintliver=VmaxKM·E~T.

g

New CLintliver=VmaxKM+ET·E~T=CanonicalCLintliver·KMKM+ET. See Supplementary Excel File for detailed calculation.